Previous studies have linked migraines to an increased risk of ischaemic stroke and myocardial infarction but a Danish study has now linked them with most other CV diseases and underscores the strong link with stroke.

Researchers matched 51,032 patients with migraine with 510,320 controls from the general population. During the 19-year follow up, migraine increased the risk of MI by 49 per cent, venous thromboembolism by 59 per cent and atrial fibrillation or atrial flutter by 25 per cent.

Migraine also doubled the risk of ischaemic stroke (adjusted hazard ratio [HR] 2.26) and haemorrhagic stroke (HR 1.94) but “no meaningful association” emerged between migraine and peripheral artery disease or heart failure.

The risks, particularly for stroke, were especially marked in the first year after a migraine diagnosis. For example, the risks of ischaemic stroke (HR 8.37) and haemorrhagic stroke (HR 7.89) were about eight-fold higher during the first year.

The risk of ischaemic stroke doubled (HR 2.05) and was 39 per cent higher for haemorrhagic stroke one to five years after migraine diagnosis, and 57 and 42 per cent higher at five to 19 years. At one to five years and five to 19 years after diagnosis, migraine was associated with an increased risk of MI, venous thromboembolism and atrial fibrillation or atrial flutter.

The cardiovascular risks seemed especially marked in people with migraine with aura, which increased MI risk by 74 per cent during the 19-year follow-up compared to 22 per cent in those without aura. The risk of ischaemic stroke increased by 149 and 81 per cent respectively. Haemorrhagic stroke risk rose by 82 and 70 per cent in those with and without aura respectively.

The authors suggest that, “migraine should be considered a potent and persistent risk factor for most cardiovascular diseases in both men and women”.

BMJ 2018;360:k96

Recommended

Clinical briefing: Aspirin and cancer

A growing body of evidence is suggesting that aspirin reduces the risk of certain cancers

Clinical briefing: Public vaping

The House of Commons Science and Technology Committee says the use of e-cigarettes should be allowed in mental health fa...




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.